期刊文献+

维生素D缺乏与高血压病患者血清NT-pro-BNP浓度的关系

Relationship between vitamin D deficiency and serum NT-pro-brain natriuretic peptide concentration in patients with hypertension
下载PDF
导出
摘要 目的:研究高血压病患者中维生素D的缺乏与血清N末端脑钠尿肽原(NT-pro-BNP)浓度的关系。方法:选取2009年~2012年住院高血压病患者,根据血清25.羟维生素D[25(OH)D]浓度由高到低将入选患者分为4组:A组:对照组25(OH)D浓度i〉30ng/ml;B组:20ng/ml〈25(OH)D浓度〈30ng/ml;C组:10rig/ml〈25(OH)D浓度〈20ng/ml;D组:25(OH)D浓度≤10ng/ml,测定血清NT-pro-BNP浓度,并作受试者血清各指标与血清NT-pro-BNP浓度相关性的分析。结果:B组和c组血清NT-pro-BNP浓度较对照组没有显著性差异。D组血清NT-pro-BNP浓度较对照组明显升高,差异有统计学意义(P〈0.05),D组血清NT-pro-BNP浓度较c组升高,差异有统计学意义(P〈0.05),即随着血清25(OH)D浓度的降低其血清NT-pro-BNP浓度显著升高。受试者血糖、血钙、总胆固醇、三酰甘油、糖化血红蛋白(HbAlC)、同型半胱氨酸、肌酐、甲状旁腺素与血清NT-pro-BNP浓度没有相关性。结论:维生素D的缺乏明显增加高血压病患者发生心力衰竭的风险。 AIM: To study the relationship between vitamin D deficiency and serum NT-pro-brain natriuretic peptide in hypertensive patients. METHODS : On the basis of the plasma levels of 25 (OH) D, hypertensive patients in our hospital from 2009 to 2012 were divided into four groups: control group with 25(0H) D density≥30 ng/ml, group B with 20 ng/ml 〈 25 (OH)D density 〈 30 ng/ml, group C with 10 ng/ml 〈 25 (OH) D density 〈 20 ng/ml and group D with 25 (OH) D density ~〈 10 ng/ml. Serum NT-pro-brain natriuretic peptide concentration was evaluated and the correlation between serum indexes and serum NT-pro-brain natriuretic peptide concentration was analyzed. RESULTS : A total of 150 hypertensive patients aged 30 - 85 years were included in the study. No significant difference was found in the serum NT-pro-brain natriuretic peptide concentration between groups B and C and control group (95% C I : - 38.63 - 195.92, P 〉 0. 05 ; 95% CI : 84. 44 - 311.25, P 〉 0. 05 ). Serum NT-pro-brain natli-uretic peptide concentration in group D was significantly higher than in control group (95 % CI : 181.42 - 409.99, P 〈 0. 05 ) and was significantly higher than in group C. Serum NT-pro-brain natriuretic peptide concentration in each group markedly increased with the decrease of plasma levels of 25 (OH) D. No correlation was found between the serum NT-pro-brain natriuretic peptide concentration and serum indexes including blood sugar, blood calcium, total cholesterol, triglyceride, homocysteine, creatinine and parathormone. CONCLUSION: Vitamin D deficiency obviously enhances the risk of heart failure in hypertensive patients.
出处 《心脏杂志》 CAS 2013年第5期540-542,共3页 Chinese Heart Journal
关键词 维生素D 高血压 原发性 脑钠尿肽原 心力衰竭 vitamin D hypertensive disease NT-pro-brain natriuretic peptide heart failure
  • 相关文献

参考文献10

  • 1Demir M,Uyan U,Melek M.The effect of vitamin D deficiency on the atrial fibrillation[J].Clin Appl Thromb Hemost,2012,23(7):565-569.
  • 2Milovanovic M,Pesic G,Nikolic V,et al.Vitamin D deficiency is associated with increased IL17 and TNFα levels in patients with chronic heart failure[J].Arq Bras Cardiol,2012,98(3):259-265.
  • 3Cozzolino M,Bruschetta E,Stucchi A,et al.Role of vitamin D receptor activators in cardiorenal syndromes[J].Semin Nephrol,2012,32(1):63-69.
  • 4Pitz S,Tomaschitz A,Drechsler C,et al.Vitamin D deficiency and myocardial diseases[J].Mol Nutr Food Res,2010,54(8):1103-1113.
  • 5Pourdjabbar A,Dwivedi G,Haddad H,et al.The role of vitamin D in chronic heart failure[J].Curr Opin Cardiol,2013,28(2):216-222.
  • 6李昊,殷艳蓉,田刚.连续静脉血液滤过治疗对血浆NT-proBNP水平的影响及其意义[J].心脏杂志,2012,24(4):498-502. 被引量:1
  • 7Wetmore JB,Gadi R,Lee JH,et al.Association of 25hydroxyvitamin D deficiency with NT-pro-BNP levels in patients with acute myocardial infarction:a crosssectional analysis[J].BMC Res Notes 2011,15(4):542.
  • 8Li X,Speer MY,Yang H,et al.Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin[J]. Arterioscler Thromb Vasc Biol,2010,30(2):321-326.
  • 9Fall T,Shiue I,Berge af Geijerstam P,et al.Relations of circulating vitamin D concentrations with left ventricular geometry and function[J].Eur J Heart Fail,2012,14(9):985-991.
  • 10Liss Y,Frishman WH.Vitamin D:a cardioprotective agent?[J].Cardiol Rev,2012,20(1):38-44.

二级参考文献12

  • 1Omland T. Advances in congestive heart failure management in the intensive care unit : B-type natriuretic peptides in evaluation of acute heart failure[J]. Crit Care Med, 2008, 36( 1 suppl) :17 -27.
  • 2Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease[ J]. J Am Soc Nephrol, 2008, 19(9) : 1643 - 1652.
  • 3Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molec- ular biology, and clinical relevance of natriuretic peptides [ J ]. JCardiol, 2011,57(2) :131 - 140.
  • 4Nishikimi T, Minamino N, Ikeda M, et al. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure: different proBNP-108 to BNP-32 ratios in atrial and ventricular overload [ J ]. Heart, 2010, 96(6) :432 -439.
  • 5Dautin G, Boudjeltia S, Soltani Z, et al. The changes in NT-proBNP plasma concentrations during dialysis are highly dependent of the dialysis membrane uhrafihration coefficient [ J ]. Clinica Chimica Acta, 2007, 376(1 -2):237-239.
  • 6Bargnoux AS, Klouche K, Fareh J, et al. Prohormone brain natri- uretic peptide ( proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventrieular function, fluid removal and effect of hemodiafiltration [ J ]. Clin Chem Lab Med, 2008, 46(7) :1017 -1024.
  • 7Januzzi JL, Morss A, Tung R, et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study [ J ]. Crit Care, 2006, 10 ( 1 ) : R37.
  • 8Kuwahara K, Saito Y, Harada M, et al. Involvement of cardio- throphin-1 in cardiac myocyte-nonmyocyte interactions during hyper- throphy of rat cardiac myocytes in vitro [ J ]. Circulation, 1999, 100 (10) : 1116 -1124.
  • 9Witthaut R, Busch C, Fraunberger P, et al. Plasma atrial natriuret- ic peptide and brain natriuretic peptide are increased in septic shock : impact of interleukin-6 and sepsis associated left ventricular dysfunction[J]. Intensive Care Med, 2003, 29(10) :1696 - 1702.
  • 10Baggish AL, Kimmenade RR, januzzi JL. Amino-terminal pro- B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure [ J ]. Am J Cardi- ol, 2008, 101(3A) :49 -55.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部